Michael Bouvet

Michael Bouvet

University of California, San Diego

H-index: 78

North America-United States

About Michael Bouvet

Michael Bouvet, With an exceptional h-index of 78 and a recent h-index of 37 (since 2020), a distinguished researcher at University of California, San Diego,

His recent articles reflect a diverse array of research interests and contributions to the field:

Targeting Methionine Addiction Combined With Low-dose Irinotecan Arrested Colon Cancer in Contrast to High-dose Irinotecan Alone, Which Was Ineffective, in a Nude-mouse Model

TRIF-IFN-I pathway in Helicobacter-induced gastric cancer in an accelerated murine disease model and patient biopsies

Extensive Synergy Between Recombinant Methioninase and Eribulin Against Fibrosarcoma Cells But Not Normal Fibroblasts

The Expression of the Claudin Family of Proteins in Colorectal Cancer

Colorectal cancer murine models: Initiation to metastasis

Methionine restriction of glioma does not induce MGMT and greatly improves temozolomide efficacy in an orthotopic nude-mouse model: A potential curable approach to a clinically …

A human serum albumin-indocyanine green complex offers improved tumor identification in fluorescence-guided surgery

Recombinant Methioninase Decreased the Effective Dose of Irinotecan by 15-fold Against Colon Cancer Cells: A Strategy for Effective Low-toxicity Treatment of Colon Cancer

Michael Bouvet Information

University

Position

Professor of Surgery

Citations(all)

19845

Citations(since 2020)

6682

Cited By

16176

hIndex(all)

78

hIndex(since 2020)

37

i10Index(all)

339

i10Index(since 2020)

202

Email

University Profile Page

Google Scholar

Top articles of Michael Bouvet

Targeting Methionine Addiction Combined With Low-dose Irinotecan Arrested Colon Cancer in Contrast to High-dose Irinotecan Alone, Which Was Ineffective, in a Nude-mouse Model

In Vivo

2024/5/1

Michael Bouvet
Michael Bouvet

H-Index: 47

TRIF-IFN-I pathway in Helicobacter-induced gastric cancer in an accelerated murine disease model and patient biopsies

Iscience

2024/4/19

Extensive Synergy Between Recombinant Methioninase and Eribulin Against Fibrosarcoma Cells But Not Normal Fibroblasts

Anticancer Research

2024/3/1

The Expression of the Claudin Family of Proteins in Colorectal Cancer

2024/2/24

Michael Bouvet
Michael Bouvet

H-Index: 47

Colorectal cancer murine models: Initiation to metastasis

2024/2/14

Methionine restriction of glioma does not induce MGMT and greatly improves temozolomide efficacy in an orthotopic nude-mouse model: A potential curable approach to a clinically …

Biochemical and Biophysical Research Communications

2024/2/5

Yusuke Aoki
Yusuke Aoki

H-Index: 3

Michael Bouvet
Michael Bouvet

H-Index: 47

A human serum albumin-indocyanine green complex offers improved tumor identification in fluorescence-guided surgery

Translational Cancer Research

2024/1/1

Recombinant Methioninase Decreased the Effective Dose of Irinotecan by 15-fold Against Colon Cancer Cells: A Strategy for Effective Low-toxicity Treatment of Colon Cancer

Anticancer Research

2024/1/1

Michael Bouvet
Michael Bouvet

H-Index: 47

Humanized Anti-Carcinoembryonic Antigen Antibodies Brightly Target and Label Gastric Cancer in Orthotopic Mouse Models

Journal of Surgical Research

2024/1/1

The combination of methioninase and ethionine exploits methionine addiction to selectively eradicate osteosarcoma cells and not normal cells and synergistically down-regulates …

Cancer Genomics & Proteomics

2023/12/1

Yusuke Aoki
Yusuke Aoki

H-Index: 3

Michael Bouvet
Michael Bouvet

H-Index: 47

Mucins as contrast agent targets for fluorescence-guided surgery of pancreatic cancer

2023/3/29

Prakash Radhakrishnan
Prakash Radhakrishnan

H-Index: 16

Michael Bouvet
Michael Bouvet

H-Index: 47

Use of Fluorescence Guidance in Endocrine Surgery

2023/11/28

Michael Bouvet
Michael Bouvet

H-Index: 47

Fluorescence conjugated anti-mucin antibodies to target and brightly label colorectal and pancreatic cancer

2023/3/17

Michael Bouvet
Michael Bouvet

H-Index: 47

Recombinant methioninase lowers the effective dose of regorafenib against colon-cancer cells: A strategy for widespread clinical use of a toxic drug

Cancer Diagnosis & Prognosis

2023/11

Michael Bouvet
Michael Bouvet

H-Index: 47

Proceduralist criteria for evaluating interface utility of novel imaging modalities in early phase clinical trials: evaluating the need for standardized criteria

2023/3/14

Recombinant-methioninase-producing Escherichia coli Instilled in the Microbiome Inhibits Triple-negative Breast Cancer in an Orthotopic Cell-line Mouse Model

Cancer Diagnosis & Prognosis

2023/11

Michael Bouvet
Michael Bouvet

H-Index: 47

Oncogenes and methionine addiction of cancer: Role of c-MYC

Cancer genomics & proteomics

2023/3/1

Yusuke Aoki
Yusuke Aoki

H-Index: 3

Michael Bouvet
Michael Bouvet

H-Index: 47

PEGylated Fluorescent Anti-Carcinoembryonic Antigen Antibody Labels Colorectal Cancer Tumors in Orthotopic Mouse Models

Journal of Surgical Research

2023/11/1

Lin Li
Lin Li

H-Index: 51

Michael Bouvet
Michael Bouvet

H-Index: 47

The mucin family of proteins: candidates as potential biomarkers for colon cancer

2023/2/27

Michael Bouvet
Michael Bouvet

H-Index: 47

Development of Imaging Probes for Fluorescence Guided Surgery of GI and Endocrine Tumors

Development

2023/10/15

Michael Bouvet
Michael Bouvet

H-Index: 47

See List of Professors in Michael Bouvet University(University of California, San Diego)